ChAgly CD3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ChAgly CD3, covering 2008-09-29 to 2008-09-29. Get the full timeline:
Most recent: Clinical Trial Update: Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients [Phase 2]